Dcgi
Sep 12, 2020 23:38
DCGI has also directed the Pune-based vaccine producer to closely follow up on all the individuals who have been administered vaccine doses as part of the trial so far and submit a report immediately. read more
Sep 12, 2020 07:42
Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. read more
Aug 23, 2020 09:16
Human trials of Covaxin started about two week ago and it may be available by the end of the year, Union minister of health and family welfare Harsh Vardhan has said. read more
Jul 26, 2020 16:28
Considering the unmet medical needs in Covid-19, Itolizumab, an already approved drug of Biocon, used for treating psoriasis - a skin condition - was approved for “restricted emergency use” in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently. read more
Jul 25, 2020 21:02
The three firms are Cadila Healthcare, MDAAC International and N W Overseas while the 16 companies include Transasia Bio-Medicals, Cosmic Scientific, Inbios India, S D Biosensor, Accurex Biomedicals, Biohouse Solutions and Trivitron Healthcare among others. read more
Jul 12, 2020 01:45
ICMR and the All India Institute of Medical Sciences said “indiscriminate use or use in conditions for which they (investigational therapies) are not desirable may cause more harm than good”. read more
Jul 11, 2020 23:59
Itolizumab is a monoclonal antibody approved for the treatment of severe chronic plaque psoriasis. Monoclonal antibodies are lab-made proteins that act like human antibodies in the immune system and fight against foreign molecules. read more
Jul 09, 2020 23:48
Earlier, ICMR DG Balram Bhargava wrote a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous Covid-19 vaccine in a fast track method so that results of a clinical trial can be launched by August 15. read more
Jul 09, 2020 00:07
Doctors blame increased demand and limited supply of the medicine for its shortage since the Union health ministry on June 13 allowed its emergency use for treating Covid-19 patients with moderate symptoms. read more
Jul 08, 2020 00:20
The drugs controller acted on a complaint by Local Circles, an independent community engagement and social media platform, which pointed to the problem of dugs shortage because of alleged black-marketing. read more
Jun 21, 2020 16:53
Here are today’s top news, analysis and opinion at 5 PM. Know all about the latest news and other news updates from Hindustan Times. read more
Jun 20, 2020 14:01
The drug will be available as a 200 mg tablet at a maximum retail price (MRP) of Rs 3,500 for a strip of 34 tablets, Glenmark Pharmaceuticals said. read more
May 01, 2020 03:49
Favipiravir, sold under the brand name Avigan of Fujifilm Toyama Chemical Co. Ltd, Japan, a subsidiary of Fujifilm Corporation, is an antiviral medication used to treat influenza in Japan. read more
Mar 26, 2019 07:18
Requirement of a local clinical trial may be waived for approval of new drug if it is approved and marketed in any of the countries to be specified by the drug controller general of India (DCGI) with approval of government from time to time and certain... read more
Apr 24, 2018 22:34
Drug controller-II, Jaipur, has said that a second DCGI team will probe the matter further. read more
